In the Occupational Intakes of Radionuclides (OIR) report series, the International Commission on Radiological Protection (ICRP) published updated biokinetic models and dosimetric data associated with the internal exposure of workers, which are consistent with the recommendations of ICRP Publication 103. The present study focused on the application of the new OIR uranium model published in ICRP Publication 137, which is relevant for the interpretation of measurements of activity in the body and in excreta, and for calculating the committed effective dose. The main objective of this study was to assess the impacts of the new OIR biokinetic models and dose coefficients compared with the old ones based on ICRP Publications 60/78/119. CIEMAT and the University of Salamanca in Spain have been working on re-interpreting in vitro bioassay data obtained from workers with long-term exposure to inhaling uranium oxides during the fabrication of nuclear fuel elements using low enriched uranium, which is now classified as OIR type M/S material. The effects on the retention/excretion models and dose coefficients were studied for 234U, 235U, 238U, and the uranium mixture. Committed effective doses were re-assessed using BIOKMOD code by applying the new OIR excretion model and dose coefficients considering acute and/or chronic inhalation intake scenarios. A reduction by roughly a factor of four was obtained compared with former doses based on ICRP Publications 60/78/119, which is an important effect to take into consideration.